Vinh-Hung, Vincent http://orcid.org/0000-0002-6403-6120
Everaert, Hendrik
Gorobets, Olena
Van Parijs, Hilde
Verfaillie, Guy
Vanhoeij, Marian
Storme, Guy
Fontaine, Christel
Lamote, Jan
Perrin, Justine
Farid, Karim
Nguyen, Nam P.
Verschraegen, Claire
De Ridder, Mark
Article History
Received: 6 August 2020
Accepted: 26 February 2021
First Online: 10 March 2021
Declarations
:
: Vincent Vinh-Hung received non-financial support from AddMedica, AstraZeneca, Bayer HealthCare SAS, Bristol-Myers Squibb, Ipsen Pharma, Janssen-Cilag, GlaxoSmithKline, Pfizer SAS, Roche SAS, Sanofi Aventis France, Sepropharm International. Vincent Vinh-Hung and Nam P. Nguyen hold a patent on the Mean absolute dose deviation, unrelated to the present study. Olena Gorobets received non-financial support from AstraZeneca. The other authors declare that they have no conflict of interest.
: All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. The study was approved by the Medical Ethics Committee of the Universitair Ziekenhuis Brussel. Informed consent was obtained from all individual participants included in the study. The study was registered at: ExternalRef removed.